10:04 AM EDT, 10/15/2025 (MT Newswires) -- Hims & Hers Health ( HIMS ) said Tuesday that it will now provide perimenopause and menopause care under its Hers platform.

The company said the new service will help its Hers unit surpass $1 billion in annual revenue next year.

The company said that eligible customers will now be provided personalized menopause and perimenopause treatment plans through Hers, which may include prescription medication in pill, patch, or cream forms.

Treatments for eligible customers may include estradiol and progesterone, the company added.

Shares of the company were up 3.8% in recent Tuesday premarket activity.

Price: 56.08, Change: +2.06, Percent Change: +3.81